Switching antidepressant class does not improve response or remission in treatment-resistant depression

Autor: Joseph Zohar, Raffaella Calati, Sylvie Linotte, Pierre Oswald, Isabelle Massat, Stuart Montgomery, Joseph Bollen, Koen Demyttenaere, Siegfried Kasper, Daniel Souery, Yves Lecrubier, Anastasios Konstantinidis, Alessandro Serretti, Julien Mendlewicz
Přispěvatelé: Souery, D, Serretti, A, Calati, R, Oswald, P, Massat, I, Konstantinidis, A, Linotte, S, Bollen, J, Demyttenaere, K, Kasper, S, Lecrubier, Y, Montgomery, S, Zohar, J, Mendlewicz, J, Souery D., Serretti A., Calati R., Oswald P., Massat I., Konstantinidis A., Linotte S., Bollen J., Demyttenaere K., Kasper S., Lecrubier Y., Montgomery S., Zohar J., Mendlewicz J.
Rok vydání: 2011
Předmět:
Zdroj: Journal of clinical psychopharmacology. 31(4)
ISSN: 1533-712X
Popis: Objective: The management of treatment-resistant depression is a much debated issue. In particular, the evidence supporting the commonly suggested sequential use of antidepressants from 2 different pharmacological classes is weak.This retrospective study was undertaken to investigate whether there is a better response in nonresponders switched to a different class of antidepressants (across-class) compared with nonresponders switched to an antidepressant from the same class (within-class). Methods: Three hundred forty patients with primary major depressive disorder were recruited in the context of a European multicenter project. Subjects whose current depressive episode had failed to respond to a first antidepressant trial of adequate dose and duration were included. Results: There was no significant difference in response or remission rates between the across-class and within-class groups after controlling for possible confounders. Conclusions: In depressed nonresponders to a previous antidepressant treatment, switching to a different class of antidepressants was not associated with a better response or remission rate. © 2011 Lippincott Williams & Wilkins.
Databáze: OpenAIRE